Japan Probes Alzheimer's Study Funded In Part By 11 Drug Makers
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma, Bristol-Myers Squibb, Pfizer and Takeda Pharmaceutical are among 11 drug manufacturers that supported a study now being investigated to see if false data was used in an Alzheimer's disease study in Japan.